See the Complete Picture.
Published loading...Updated

Seven-minute cancer treatment jab to be rolled out in England in world-first

  • Patients in England will have access to a new seven-minute cancer treatment jab that cuts treatment time by up to 75%. The injection technology, approved by the MHRA, allows patients to switch from intravenous delivery to injections, saving valuable time.
  • The treatment, known as atezolizumab or Tecentriq, is a checkpoint inhibitor that helps the immune system find and kill cancer cells. It is given to patients with various cancers, including lung, breast, liver, and bladder.
  • NHS England expects the majority of the 3,600 patients starting atezolizumab treatment each year to switch to injections, freeing up time in chemotherapy units. Patients receiving intravenous chemotherapy alongside atezolizumab may continue with the transfusion.
Insights by Ground AI
Does this summary seem wrong?

18 Articles

All
Left
4
Center
6
Right
7
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 41% of the sources lean Right
41% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Independent broke the news in London, United Kingdom on Tuesday, August 29, 2023.
Sources are mostly out of (0)